Ultragenyx Wins Big in Blood Sugar Study
Ultragenyx Pharma shares made a handy gain to close out the week after the company announced positive results from its midstage trial for the treatment of glycogen storage disease type Ia.
Ultragenyx Pharma shares made a handy gain to close out the week after the company announced positive results from its midstage trial for the treatment of glycogen storage disease type Ia.
A prominent health care analyst has identified his top health care stock picks for 2019, and some are somewhat speculative.
Selecta Biosciences shares pushed higher on Friday after the company provided an update on its new streamlined structure under its new president and CEO.
Epizyme shares jumped on Friday after the company announced a set of pipeline updates as well as a key update from the FDA.
Novavax shares jumped early on Friday after the company reported that its midstage flu vaccine had some positive results.
The air quality in one of the world's largest cities became so bad in the past two days that it is not fit to breathe, even for healthy people.
Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen for its treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on…
Catabasis shares jumped on Thursday after the company provided an update from its late-stage trial for edasalonexent in Duchenne muscular dystrophy.
Atara Biotherapeutics shares dipped on Thursday after the company provided a few business updates.
Sesen Bio shares took a beating on Thursday despite posting positive data for its late-stage trial for patients with high-grade non-muscle invasive bladder cancer.
DBV Technologies shares made a handy gain on Thursday after the company announced that it would be making some changes in its senior leadership ahead of its anticipated resubmission of its Viaskin Peanut Biologics…
Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday night's closing stock price.
Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series of approvals in Japan.
Girl Scout Cookies have been sold since 1917. Among the many flavors and shapes, there has never been a gluten-free product. That changed this year.
Here is a review of the outlook and expectations for 2019 in seven top biotechs valued at $20 billion or more.